Clinical trial · Observational
Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
NCT07191496CI-TRIAL-00108726terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): \<75% participation
Summary
Brief summary (as posted)
To assess the quality of life for women who were pregnant during their breast cancer treatment.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Survivor | — | UNRESOLVED | — |
| Pregnant Women | — | UNRESOLVED | — |
| Quality of Lifte | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- QOL Questionnaires
- timeFrame
- Through study completion; an average of 1 year
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Eligibility Criteria * Female, any current age and any age at diagnosis * Documented diagnosis of breast cancer during pregnancy * Documentation of receiving chemotherapy during pregnancy * Alive with no evidence of disease at time of recruitment * Able to reach and speak English Exclusion Criteria * Any woman who delayed and received their chemotherapy after delivery. * Any woman who was diagnosed with breast cancer before or after their pregnancy. * Any woman whom there is documentation of inability to provide consent in the medical record
References
Publications (0)
Data not yet available
No reference posted for this study.